These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 24325117)

  • 21. Association of Serum Soluble CD163 with Polymyositis and Dermatomyositis, Especially in Anti-MDA5 Antibody-positive Cases.
    Kawasumi H; Katsumata Y; Nishino A; Hirahara S; Kawaguchi Y; Kuwana M; Yamanaka H
    J Rheumatol; 2018 Jul; 45(7):947-955. PubMed ID: 29657141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19 or clinical amyopathic dermatomyositis associated rapidly progressive interstitial lung disease? A case report.
    Cao M; Zhang S; Chu D; Xiao M; Liu X; Yu L; Li J; Huang Y; Fang F
    BMC Pulm Med; 2020 Nov; 20(1):304. PubMed ID: 33213393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interstitial lung disease related to dermatomyositis. Comparative study with patients without lung involvement.
    Grau JM; Miró O; Pedrol E; Casademont J; Masanés F; Herrero C; Haussman G; Urbano-Márquez A
    J Rheumatol; 1996 Nov; 23(11):1921-6. PubMed ID: 8923367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysregulation of the type I interferon system in adult-onset clinically amyopathic dermatomyositis has a potential contribution to the development of interstitial lung disease.
    Sun WC; Sun YC; Lin H; Yan B; Shi GX
    Br J Dermatol; 2012 Dec; 167(6):1236-44. PubMed ID: 23013528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-CADM-140/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease.
    Sato S; Kuwana M; Fujita T; Suzuki Y
    Mod Rheumatol; 2013 May; 23(3):496-502. PubMed ID: 22644102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis.
    Chen Z; Cao M; Plana MN; Liang J; Cai H; Kuwana M; Sun L
    Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1316-24. PubMed ID: 23908005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients.
    Marie I; Hatron PY; Dominique S; Cherin P; Mouthon L; Menard JF
    Arthritis Rheum; 2011 Nov; 63(11):3439-47. PubMed ID: 21702020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interstitial lung disease in clinically amyopathic dermatomyositis with and without anti-MDA-5 antibody: to lump or split?
    Ikeda S; Arita M; Morita M; Ikeo S; Ito A; Tokioka F; Noyama M; Misaki K; Notohara K; Ishida T
    BMC Pulm Med; 2015 Dec; 15():159. PubMed ID: 26651481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated Erythrocyte Sedimentation Rate Is Predictive of Interstitial Lung Disease and Mortality in Dermatomyositis: a Korean Retrospective Cohort Study.
    Go DJ; Lee EY; Lee EB; Song YW; Konig MF; Park JK
    J Korean Med Sci; 2016 Mar; 31(3):389-96. PubMed ID: 26955239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interstitial lung disease in polymyositis and dermatomyositis.
    Chen IJ; Jan Wu YJ; Lin CW; Fan KW; Luo SF; Ho HH; Liou LB; Tsai WP; Chen JY; Yang CH; Kuo CF; Yu KH
    Clin Rheumatol; 2009 Jun; 28(6):639-46. PubMed ID: 19247576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Risk factors associated with cardiac involvement in patients with dermatomyositis/polymyositis].
    Zuo C; Wei XD; Ye YL; Liang Y; Yin G; Yang M; Xie QB
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):801-4, 809. PubMed ID: 24325116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimelanoma Differentiation-associated Gene 5 Antibody: Expanding the Clinical Spectrum in North American Patients with Dermatomyositis.
    Moghadam-Kia S; Oddis CV; Sato S; Kuwana M; Aggarwal R
    J Rheumatol; 2017 Mar; 44(3):319-325. PubMed ID: 28089977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease.
    Gono T; Kaneko H; Kawaguchi Y; Hanaoka M; Kataoka S; Kuwana M; Takagi K; Ichida H; Katsumata Y; Ota Y; Kawasumi H; Yamanaka H
    Rheumatology (Oxford); 2014 Dec; 53(12):2196-203. PubMed ID: 24970922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcome of patients with polymyositis/ dermatomyositis and anti-PM-Scl antibody.
    Marie I; Lahaxe L; Benveniste O; Delavigne K; Adoue D; Mouthon L; Hachulla E; Constans J; Tiev K; Diot E; Levesque H; Boyer O; Jouen F
    Br J Dermatol; 2010 Feb; 162(2):337-44. PubMed ID: 19845665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Idiopathic inflammatory myopathy associated with malignancy: a retrospective cohort of 151 Korean patients with dermatomyositis and polymyositis.
    So MW; Koo BS; Kim YG; Lee CK; Yoo B
    J Rheumatol; 2011 Nov; 38(11):2432-5. PubMed ID: 21844145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Surfactant proteins-A and D as important serum markers for interstitial lung disease in patients with polymyositis or dermatomyositis].
    Chen F; Shu XM; Wang DX; Xie Y; Wang GC
    Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(31):2182-5. PubMed ID: 23158422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM.
    Koga T; Fujikawa K; Horai Y; Okada A; Kawashiri SY; Iwamoto N; Suzuki T; Nakashima Y; Tamai M; Arima K; Yamasaki S; Nakamura H; Origuchi T; Hamaguchi Y; Fujimoto M; Ishimatsu Y; Mukae H; Kuwana M; Kohno S; Eguchi K; Aoyagi K; Kawakami A
    Rheumatology (Oxford); 2012 Jul; 51(7):1278-84. PubMed ID: 22378718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and serological features of patients with dermatomyositis complicated by spontaneous pneumomediastinum.
    Ma X; Chen Z; Hu W; Guo Z; Wang Y; Kuwana M; Sun L
    Clin Rheumatol; 2016 Feb; 35(2):489-93. PubMed ID: 26149923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy of calcineurin inhibitors for the treatment of interstitial lung disease associated with polymyositis/dermatomyositis.
    Kurita T; Yasuda S; Amengual O; Atsumi T
    Lupus; 2015 Jan; 24(1):3-9. PubMed ID: 25297551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors Associated with Interstitial Lung Disease in Patients with Polymyositis and Dermatomyositis: A Systematic Review and Meta-Analysis.
    Zhang L; Wu G; Gao D; Liu G; Pan L; Ni L; Li Z; Wang Q
    PLoS One; 2016; 11(5):e0155381. PubMed ID: 27171228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.